The Petri Dish: Takeda taps Selecta for gene therapy, BICO makes another buy
While some in the life sciences industry create drugs and devices to tackle the Covid-19 pandemic, their colleagues are busy as ever raising money, testing new drugs, expanding facilities and more. Here's The Petri Dish, a roundup of news that may get overlooked amid the influx of Greater Boston life sciences and health care happenings.
BICO makes another acquisition
Just over a month after restructuring, Boston-based BICO — short for "bioconvergence" — has acquired another company, this time…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Rowan Walrath Source Type: news
More News: American Health | COVID-19 | Gene Therapy | Genetics | Health Management | Mergers and Aquisitions | Pandemics